COLCHICINE : COVID-19 Trial Underway
COLCHICINE : COVID-19 Trial Underway

Researchers in the United States, Canada & Europe are testing Colchicine on approximately 6,000 participants for a period of 30 days.

The trial is to find out whether short-term treatment with colchicine will reduce lung complications and the rate of death in COVID-19 patients.

Colchicine is thought to decrease the ‘cytokine storm’ or inflammation that causes complications and death, in patients with COVID-19.

Colchicine has also currently been approved by FDA for gout and familial mediterranean fever.

Share this article
Share on facebook
Share on twitter
Share on linkedin
0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Upload Test Report Form

    Any Query?

    ×

     

    Hello!

    × How can I help you?